RCN3028

N/A

Report date: 2025/08/15 15:14:50
NME

Base Information

Drug NameRCN3028
Drug Alias NameRCN-3028RCN3028
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsDopamine D2 receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorDopamine D2 receptor
Therapy Area/IndicationsHot FlashesDysmenorrheaBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesYung Shin Pharm Ind Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYung Shin Pharm Ind Co Ltd
Active IndicationsN/A
Inactive IndicationsHot FlashesDysmenorrheaBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A